Several prognostic and predictive TF markers have been identified for BC; for instance, the TF KLF4 has been reported to serve as an independent predictive marker for pathological complete remission in BC following neoadjuvant chemotherapy (Dong et al., 2014). Here, TF is linked to breast cancer.